We have been waiting for this trial, says Leslie Cho, MD, Co-Section Head of Preventive Cardiology at Cleveland Clinic
Editor: William Navarre, University of Toronto, CANADA Received: January 9, 2023
Daily subcutaneous injection for 4 weeks, followed by a rest period of 2 to 4 weeks
Tirzepatide compared to semaglutide already showed that dual-receptor agonism outperforms single-receptor activation
Esophagectomy results poor at private equity owned hospitals JAMA Surgery reported in January that patients on Medicare who had esophagectomies (removal of a portion of the esophagus) at hospitals owned by private equity companies from 2016-2020 had higher rates of mortality and complications even though they had fewer comorbidities (they were healthier) and they were less likely to be treated for cancer
Enhanced quality of life Losing weight with Semaglutide GLP-1 injections can improve quality of life, as the treatment often results in better self-esteem, confidence, and overall health
